Progeny 3 Inc’s Oscar Health OSCR Stock Holding History

Progeny 3 Inc’s Portfolio OSCR Stock Details OSCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-100,584	Closed	-$427K	–	29
2022 Q2	$427K	Buy	+100,584	New	+$640K	0.09%	22

Other funds holding OSCR

Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

VK Services Menlo Park, California $543K AUM 174.84% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

SAM

Southeastern Asset Management Memphis, Tennessee $2.03B AUM 7.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCMNY

Thrive Capital Management (New York) New York $344M AUM 25.6% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

LGI

Lakestar Growth I St. Peter Port, Guernsey $11.5M AUM 71.31% 1-Year Est. Return

Progeny 3 Inc's OSCR Position: Q3 2022 in Review

Progeny 3 Inc sold out of Oscar Health (OSCR) in Q3 2022, closing a stake of 100,584 shares — an estimated $427K sold.

Progeny 3 Inc first reported a position in OSCR in Q2 2022 and held it in 1 quarter. The position peaked at $427K in Q2 2022. 133 funds tracked by Wall St. Rank hold OSCR as of Q3 2022.

Progeny 3 Inc reported no remaining Oscar Health position as of Q3 2022 after selling out during the quarter.
Progeny 3 Inc sold 100,584 Oscar Health shares in Q3 2022, an estimated $427K.
Progeny 3 Inc first reported a position in Oscar Health in Q2 2022 and held it in 1 quarter.
Progeny 3 Inc's Oscar Health position peaked at $427K in Q2 2022.
133 funds tracked by Wall St. Rank held Oscar Health as of Q3 2022.

Based on Progeny 3 Inc's 13F filing for Q3 2022, filed 14 Nov 2022.